OPI 409 (Chlordiazepoxide and Clidinium 5 mg / 2.5 mg)

Pill imprint OPI 409 has been identified as Chlordiazepoxide hydrochloride and clidinium bromide 5 mg / 2.5 mg.

Chlordiazepoxide/clidinium is used in the treatment of irritable bowel syndrome; enterocolitis; peptic ulcer and belongs to the drug class anticholinergics/antispasmodics. There is positive evidence of human fetal risk during pregnancy. Chlordiazepoxide/clidinium 5 mg / 2.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Chlordiazepoxide hydrochloride and clidinium bromide

Imprint:

OPI 409

Strength:

5 mg / 2.5 mg

Color:

Green

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Anticholinergics/antispasmodics

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

4 - Some potential for abuse

Manufacturer:

Oceanside Pharmaceuticals, Inc.

National Drug Code (NDC):

68682-0409

Inactive Ingredients:

corn starch
lactose
magnesium silicate
methylparaben
propylparaben
potassium sorbate
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Green No. 3

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.